CLOs on the Move

AcelRx

www.acelrx.com

 
AcelRx Pharmaceuticals Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe acute pain. The Company`s product candidates, DSUVIA™ (known as ARX-04 outside of the United States) and ZALVISO®, are designed to deliver sufentanil, a strong opioid analgesic, via a non-invasive, sublingual formulation in medical supervised settings. DSUVIA is designed to deliver sublingual tablets containing 30 mcg sufentanil via a disposable, pre-filled, single-dose applicator. The Phase 3 clinical program has completed and assessed the investigational product in the treatment of moderate-to-severe acute pain in patients who had undergone surgery or ...
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million
  • www.acelrx.com
  • 351 Galveston Drive
    Redwood City, CA USA 94063
  • Phone: 650.216.3500

Executives

Name Title Contact Details
Ruben Garcia
 General Counsel and Corporate Secretary Profile

Similar Companies

Discovery Laboratories Inc

Discovery Laboratories, Inc. is a specialty biotechnology company focused on advancing a new standard in respiratory critical care. Discovery Labs` technology platform includes its novel proprietary KL4 surfactant, a synthetic, peptide-containing surfactant that is structurally similar to pulmonary surfactant, and its proprietary drug delivery technologies being developed to enable efficient delivery of aerosolized KL4 surfactant and other inhaled therapies. Discovery Labs` strategy is initially focused on neonatology and improving the management of respiratory distress syndrome (RDS) in premature infants. Discovery Labs believes that its RDS product portfolio has the potential to become the new standard of care for RDS and, over time, enable the treatment of a significantly greater number of premature infants who could benefit from surfactant therapy that are currently not being treated. In many pulmonary diseases, including RDS, acute lung injury (ALI), and other respiratory conditions, surfactant is either deficient or may fail to function properly. Our precision-engineered, peptide-containing KL4 surfactant has been designed to mimic the essential function of human pulmonary surfactant and may have the potential to address conditions such as these. We are developing our proprietary delivery technologies to one day enable efficient, targeted upper-respiratory or alveolar delivery of our KL4 surfactant in aerosolized form to allow for a gentler, less invasive delivery approach. These same delivery systems may also potentially be used to deliver a variety of additional aerosolized medicines safely and in a simplified way compared with the current standard of care.

Radiology Alliance, P.C.

Radiology Alliance, P.C. is a Nashville, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Best Formulations

Best Formulations is a Rowland Heights, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Swissmedica

Swissmedica is a Mississauga, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Sunquest Information Systems

Sunquest Information Systems, Inc. provides healthcare information systems to large and mid-sized hospitals, clinics and other facilities, including integrated delivery networks comprised of multi-entity, multi-site healthcare organizations.